StocksI › IPGDF

IGO Limited (IPGDF) — Earnings Call X-Ray

Our AI read all 16 of IPGDF's earnings calls (2022–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q3 2025 · sign up to see
Previous Call Grade
F
Q2 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
16
2022–2025
Avg Candor
6.7/9
evasion 5.2/9
High CandorCritic AmmunitionUnderused Fixed CostsPricing Under PressureMargins ContractingDemand SlowingCutting HeadcountQuestion Left Hanging

Call-by-call analysis

🔒 Q3 2025 earnings call 2025-04-30 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q3 2025 call grade is ready
The full 37-point AI read of IPGDF's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

F Q2 2025 earnings call 2025-02-19 move ±20.3%

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid.

Guidance: maintainedDemand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: decreasing 8 analysts · 16 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 7/9
Specificity 6/9
Evasion 5/9
Confidence 6/9
Uncertainty 6/9
Promotion 4/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q2 2025 earnings call 2025-01-30 move ±12.8%

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid.

Guidance: maintainedDemand: slowingMargins: contractingPricing: under pressureCapex: decreasing 11 analysts · 26 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 7/9
Specificity 4/9
Evasion 5/9
Confidence 6/9
Uncertainty 6/9
Promotion 4/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q1 2025 earnings call 2024-10-28 move ±15.3%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid.

Guidance: maintainedDemand: mixedMargins: contractingPricing: under pressureHeadcount: cuttingCapex: flat 11 analysts · 27 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Volume step-up aheadHidden segmentDirection beats results
Candor 7/9
Specificity 6/9
Evasion 5/9
Confidence 6/9
Uncertainty 6/9
Promotion 3/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q4 2024 earnings call 2024-08-29 move ±15.5%

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid, frequently evasive.

Guidance: maintainedDemand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: flat 8 analysts · 19 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritableDirection beats results
Candor 7/9
Specificity 5/9
Evasion 6/9
Confidence 6/9
Uncertainty 5/9
Promotion 4/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q4 2024 earnings call 2024-07-30 move ±13.2%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, frequently evasive.

Guidance: maintainedDemand: mixedMargins: contractingPricing: under pressureHeadcount: cuttingCapex: increasing 9 analysts · 26 questions
⚑ Critic ammunition⚑ Question left hangingHidden segmentDirection beats results
Candor 7/9
Specificity 6/9
Evasion 6/9
Confidence 6/9
Uncertainty 7/9
Promotion 4/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q3 2024 earnings call 2024-05-05 move ±14.2%

Management held guidance steady against slowing demand and contracting margins. The delivery was frequently evasive.

Guidance: maintainedDemand: slowingMargins: contractingBacklog: shrinkingPricing: under pressureHeadcount: cuttingCapex: increasing 12 analysts · 31 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up aheadDirection beats results
Candor 6/9
Specificity 5/9
Evasion 6/9
Confidence 5/9
Uncertainty 7/9
Promotion 5/9
Stress 5/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q2 2024 earnings call 2024-02-22 move ±13%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, frequently evasive.

Guidance: loweredDemand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: flat 11 analysts · 24 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 7/9
Specificity 6/9
Evasion 6/9
Confidence 5/9
Uncertainty 7/9
Promotion 4/9
Stress 5/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q2 2024 2024-01-31 F loweredslowingcontracting 7/9 5/9
Q1 2024 2023-10-30 F maintainedslowingcontracting 6/9 7/9
Q4 2023 2023-08-31 D maintainedmixedcontracting 7/9 4/9
Q4 2023 2023-07-31 F maintainedmixedcontracting 6/9 5/9
Q3 2023 2023-04-29 D maintainedmixedcontracting 7/9 3/9
Q3 2022 2022-10-31 D maintainedacceleratingexpanding 6/9 4/9
Aug 2022 2022-08-30 D maintainedacceleratingexpanding 6/9 7/9
Q3 2022 2022-05-02 C+ maintainedacceleratingexpanding 7/9 4/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAMC · Altisource Asset ManagemAAON · AAON, Inc.AASZF · Atlantic Sapphire ASAAAT · American Assets Trust, IABCD · Cambium Learning Group'sABCO · The Advisory Board

IPG   All “I” companies    IPGLF

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.